Covid’s ‘Silver Lining’: Research Breakthroughs for Chronic Disease, Cancer, and the Common Flu
Billions of dollars invested in mRNA vaccines and covid research could yield health care dividends for decades to come.
Vaccines
321 - 340 of 828 Results
-
-
Charts Paint a Grim Picture 2 Years Into the Coronavirus Pandemic
The on-off nature of the pandemic "has led to a lot of the confusion and grumpiness," says one expert. Another compares it to the exhaustion of the American public when hearing body counts during the Vietnam War.
-
Watch: California’s Top Health Adviser on Learning to Live With Covid
KHN Senior Correspondent Samantha Young joined California Health and Human Services Secretary Mark Ghaly for an engaging conversation about how California moves forward in an environment in which covid persists, but at more manageable levels.
-
When Teens Blow Off Parents’ Pleas to Get Vaccinated, the Consequences Can Be Deadly
Kennedy Stonum, a 17-year-old high school junior, resisted getting vaccinated against covid-19, as did 20-year-old Tyler Gilreath, whose mother had nagged him for months to get the shots. Both died.
-
To Be One in a Million: ‘Who Thinks It’s Going to Be You?’
Stan Thomas’ wife, Monica Melkonian, was one of only nine people in the U.S. confirmed to have died from vaccine-induced immune thrombotic thrombocytopenia, a rare side effect associated with the Johnson & Johnson covid vaccine. For the first time, Thomas shares her story of how excited she was to get the shot, how she died, and why he remains firmly pro-vaccine.
-
J&J-Vaxxed, mRNA-Boosted, and Pondering a Third Shot
Many of the nearly 17 million U.S. members of J&J Nation, myself included, are wondering whether to set aside the current official guidance and get a second booster. Some experts say: Chill out.
-
From Alabama to Utah, Efforts to Vaccinate Medicaid Enrollees Against Covid Run Into Obstacles
Inoculation rates remain low despite massive outreach efforts and incentives from federal and state programs and Medicaid plan operators, leaving many low-income people vulnerable to the virus.
-
Readers and Tweeters Have Mental Health Care on Their Minds
KHN gives readers a chance to comment on a recent batch of stories.
-
Why Pregnant People Were Left Behind While Vaccines Moved at ‘Warp Speed’ to Help the Masses
Clinical trials of covid-19 vaccines excluded pregnant people, which left many women wondering whether to get vaccinated.
By Liz Szabo -
Covid Still Threatens Millions of Americans. Why Are We So Eager to Move On?
Those who are living with disabilities, chronic illnesses or are immunocompromised because of medications or cancer treatment feel that their needs are not being considered as states open back up and lift mask mandates.
-
KHN’s ‘What the Health?’: It’s Health Costs, Stupid (2022 Edition)
As the pandemic wanes, for now, the ever-rising cost of health care is again taking center stage. Meanwhile, a year into the Biden administration, the FDA finally has a Senate-confirmed commissioner, Dr. Robert Califf. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Hannah Wesolowski of the National Alliance on Mental Illness, about how the pandemic has worsened the nation’s mental health crisis and what can be done about it.
-
Teen Traveled to Philly to Get Vaccinated Against His Parents’ Wishes
Nicolas Montero is 16, and that’s old enough to get a vaccine on his own in Philadelphia. Vaccine regulations vary around the country and, in more than a dozen states, teens can consent to their own medical care.
-
Journalists Discuss Cracks in the Health Care System and Roadblocks to Covid Booster Shots
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
KHN’s ‘What the Health?’: FDA Takes Center Stage
Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.
-
Polio, Chickenpox, Measles, Now Covid. It’s Time to Consult History on School Vaccine Mandates
As some states adopt covid vaccine requirements, not everyone agrees mandates for children are the way forward. Taking a page from history: We have two paths to putting the pandemic behind us: a quicker, more certain one of mandatory vaccination or a stuttering, drawn-out, likely more deadly affair.
-
Missouri’s War on Public Health Shows Extent of National Rift
A public health official who said he was anti-abortion and anti-mandate for masks and covid vaccines did not pass the purity test of a Missouri senator who opposes covid public health restrictions. The senator killed the official’s nomination to be state health director, highlighting how hands may be tied in the nationwide fight against infectious diseases.
By Lauren Weber -
The Advice to Vaccinate and Test Isn’t Much Help to Parents With Kids Under 5
Many parents of children too young for vaccines are exhausted. Some feel isolated and even forgotten by those who just want to move on even as omicron continues to sweep through parts of the country.
-
In Super-Vaxxed Vermont, Covid Strikes — But Packs Far Less Punch
With its highest-in-the-nation vaccination rates, Vermont offers a glimpse of what’s possible as the U.S. learns to live with coronavirus.
By Sarah Varney -
KHN’s ‘What the Health?’: Record ACA Enrollment Puts Pressure on Congress
Temporary subsidies helped boost enrollment under the Affordable Care Act to a record 14.5 million, according to the Department of Health and Human Services. But unless Democrats in Congress extend those subsidies, many of those new enrollees will be in for a rude surprise just ahead of midterm elections. Meanwhile, the need to replace retiring Supreme Court Justice Stephen Breyer further crowds an already tight legislative schedule. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet, and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Diana Greene Foster, author of “The Turnaway Study: Ten Years, a Thousand Women, and the Consequences of Having — Or Being Denied — An Abortion.”
-
Readers and Tweeters: Give Nurse Practitioners Their Due
KHN gives readers a chance to comment on a recent batch of stories.